ERCC5 and hepatocellular carcinoma: Compared with other haplotypes, patients with the A-C-A-T haplotype of DDB2 rs2029298-rs830083-rs3781619-rs326222 showed a 2.29-fold increased HCC risk (P = 0.007, 95% CI = 1.23–4.25), while patients with the G-C-C-C-T-C-G-G haplotype of ERCC5 rs2094258-rs751402-rs2296147-rs1047768-rs4150291-rs2228959-rs4150383-rs873601 showed a significant protective function for HCC (P = 0.015, OR = 0.41, 95% CI = 0.20–0.86).